Condition: Pulmonary Tuberculosis (TB) · Sponsor: Obafemi Awolowo University Teaching Hospital
The purpose of this study is to assess pharmacokinetic parameters of atorvastatin at different doses when combined with the standard first line tuberculosis (TB) treatment regimen in adults with drug sensitive pulmonary TB. The pharmacokinetics parameters will be correlated with Pharmcodynamic measures and a PK/PD model that will identify an optimal dosing regimen of atorvastatin that is appropriate for the treatment of pulmonary tuberculosis will be developed.
This description comes directly from the study's public registry record.
Olanisun O Adewole, MD · +2348034074930 · adewolef@yahoo.co.uk , ola.adewole@oauife.edu.ng
Always discuss trial participation with your own doctor first.
| National Tuberculosis and Leprosy Training Centre, Saye | Zaria, Kaduna State, Nigeria | Recruiting |
| Federal Teaching Hospital | Katsina, Katsina State, Nigeria | Recruiting |
| Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Osun state, Nigeria | Ile-Ife, Osun State, Nigeria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07303699